Immunohistochemical study of the angiogenetic network of VEGF, HIF1α, VEGFR-2 and endothelial nitric oxide synthase (eNOS) in human breast cancer

Pathology and Oncology Research

Volumn 18, Issue 1, 2012, Pages 33-41

  Kafousi, Maria ^a   Vrekoussis, Thomas ^a,b   Tsentelierou, Eleftheria ^a   Pavlakis, Kitty ^c   Navrozoglou, Iordanis ^b   Dousias, Vassilios ^b   Sanidas, Elias ^a   Tsiftsis, Dimitrios ^a   Georgoulias, Vassilios ^a   Stathopoulos, Efstathios N ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Angiogenesis; Breast Cancer; eNOS; VEGF

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTROGEN RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INDUCIBLE NITRIC OXIDE SYNTHASE; PROGESTERONE RECEPTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST SURGERY; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CONTROLLED STUDY; DISEASE ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION;

BREAST NEOPLASMS; CHI-SQUARE DISTRIBUTION; FEMALE; HISTOCYTOCHEMISTRY; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84855275189     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-011-9413-8     Document Type: Article

References (51)

1. SB Fox DG Generali AL Harris 2007 Breast tumour angiogenesis Breast Canc Res 9 216 10.1186/bcr1796
2. H Kimura H Esumi 2003 Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis Acta Biochim Pol 50 49 59 12673346 1:CAS:528:DC%2BD3sXjt1Srtbg%3D (Pubitemid 37034227)
3. K Amano H Matsubara O Iba, et al. 2003 Enhancement of ischemia-induced angiogenesis by eNOS overexpression Hypertension 41 156 62 12511546 1:CAS:528:DC%2BD38Xps1Ohu7w%3D 10.1161/01.HYP.0000053552.86367.12 (Pubitemid 36056808)
4. D Fukumura T Gohongi A Kadambi, et al. 2001 Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability Proc Natl Acad Sci USA 98 2604 9 11226286 1:CAS:528:DC%2BD3MXhslKmsLY%3D 10.1073/pnas.041359198 (Pubitemid 32209529)
5. KB Sandau J Fandrey B Brune 2001 Accumulation of HIF-1alpha under the influence of nitric oxide Blood 97 1009 15 11159530 1:CAS:528: DC%2BD3MXht1Gju7g%3D 10.1182/blood.V97.4.1009 (Pubitemid 32154286)
6. KB Sandau HG Faus B Brune 2000 Induction of hypoxia-inducible-factor 1 by nitric oxide is mediated via the PI 3 K pathway Biochem Biophys Res Commun 278 263 7 11071882 1:CAS:528:DC%2BD3cXnvVekuro%3D 10.1006/bbrc.2000.3789
7. N Ghiso RM Rohan S Amano R Garland AP Adamis 1999 Suppression of hypoxia-associated vascular endothelial growth factor gene expression by nitric oxide via cGMP Invest Ophthalmol Vis Sci 40 1033 9 10235536 1:STN:280: DyaK1M3kvFKitw%3D%3D (Pubitemid 29211440)
8. KS Choi MK Bae JW Jeong HE Moon KW Kim 2003 Hypoxia-induced angiogenesis during carcinogenesis J Biochem Mol Biol 36 120 7 12542982 1:CAS:528: DC%2BD3sXhtV2isbY%3D 10.5483/BMBRep.2003.36.1.120
9. Y Tsuzuki D Fukumura B Oosthuyse C Koike P Carmeliet RK Jain 2000 Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1alpha-∈>∈hypoxia response element-∈>∈VEGF cascade differentially regulates vascular response and growth rate in tumors Cancer Res 60 6248 52 11103778 1:CAS:528: DC%2BD3cXos1Sksbw%3D
10. MT Chou J Wang DJ Fujita 2002 Src kinase becomes preferentially associated with the VEGFR, KDR/Flk-1, following VEGF stimulation of vascular endothelial cells BMC Biochem 3 32 12509223 10.1186/1471-2091-3-32
11. M Duval F Le Boeuf J Huot JP Gratton 2007 Src-mediated phosphorylation of Hsp90 in response to vascular endothelial growth factor (VEGF) is required for VEGF receptor-2 signaling to endothelial NO synthase Mol Biol Cell 18 4659 68 17855507 1:CAS:528:DC%2BD2sXht12js7nJ 10.1091/mbc.E07-05-0467 (Pubitemid 350060190)
12. H He VJ Venema X Gu RC Venema MB Marrero RB Caldwell 1999 Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src J Biol Chem 274 25130 5 10455194 1:CAS:528:DyaK1MXls1ymu70%3D 10.1074/jbc.274.35.25130 (Pubitemid 29404726)
13. JD Hood CJ Meininger M Ziche HJ Granger 1998 VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells Am J Physiol 274 H1054 8 9530221 1:CAS:528:DyaK1cXitVSjs7c%3D
14. BQ Shen DY Lee TF Zioncheck 1999 Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway J Biol Chem 274 33057 63 10551875 1:CAS:528:DyaK1MXntlygu70%3D 10.1074/jbc.274.46.33057 (Pubitemid 129535347)
15. BB Beleslin-Cokic VP Cokic X Yu BB Weksler AN Schechter CT Noguchi 2004 Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells Blood 104 2073 80 15205261 1:CAS:528: DC%2BD2cXotVOqur8%3D 10.1182/blood-2004-02-0744 (Pubitemid 39297859)
16. S Loibl C Strank G von Minckwitz, et al. 2005 Immunohistochemical evaluation of endothelial nitric oxide synthase expression in primary breast cancer Breast 14 230 5 15927832 1:STN:280:DC%2BD2M3ot1OisQ%3D%3D 10.1016/j.breast.2004.11.005 (Pubitemid 40740436)
17. K Mortensen IJ Christensen HJ Nielsen U Hansen LI Larsson 2004 High expression of endothelial cell nitric oxide synthase in peritumoral microvessels predicts increased disease-free survival in colorectal cancer Cancer Lett 216 109 14 15500954 1:CAS:528:DC%2BD2cXovFagtbg%3D 10.1016/j.canlet.2004.05.025 (Pubitemid 39410502)
18. K Mortensen S Holck IJ Christensen, et al. 1999 Endothelial cell nitric oxide synthase in peritumoral microvessels is a favorable prognostic indicator in premenopausal breast cancer patients Clin Cancer Res 5 1093 7 10353743 1:STN:280:DyaK1M3otVaisg%3D%3D (Pubitemid 29233224)
19. Y Nakamura H Yasuoka M Tsujimoto, et al. 2006 Nitric oxide in breast cancer: induction of vascular endothelial growth factor-C and correlation with metastasis and poor prognosis Clin Cancer Res 12 1201 7 16489074 1:CAS:528:DC%2BD28XhsFaltL0%3D 10.1158/1078-0432.CCR-05-1269 (Pubitemid 43342509)
20. ML Kwan LH Kushi E Weltzien, et al. 2009 Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors Breast Cancer Res 11 R31 19463150 10.1186/bcr2261
21. L Kalmanti K Dampaki H Dimitriou E Stiakaki V Chaniotis E Stathopoulos 2005 A morphometric approach for the evaluation of angiogenesis in acute lymphoblastic leukemia of childhood Leuk Res 29 673 7 15863208 10.1016/j.leukres.2004.08.013 (Pubitemid 40603568)
22. DM Aebersold P Burri KT Beer, et al. 2001 Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer Cancer Res 61 2911 16 11306467 1:CAS:528: DC%2BD3MXivFGqsr8%3D (Pubitemid 32691934)
23. L Nakopoulou K Stefanaki E Panayotopoulou, et al. 2002 Expression of the vascular endothelial growth factor receptor-2/Flk-1 in breast carcinomas: correlation with proliferation Hum Pathol 33 863 70 12378509 1:CAS:528:DC%2BD38XotlGgsL4%3D 10.1053/hupa.2002.126879
24. Y Takahashi SL Tucker Y Kitadai, et al. 1997 Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer Arch Surg 132 541 6 9161399 1:CAS:528:DyaK2sXjs1Kru7c%3D 10.1001/archsurg.1997.01430290087018 (Pubitemid 27215097)
25. S Meunier-Carpentier JP Dales A Djemli, et al. 2005 Comparison of the prognosis indication of VEGFR-1 and VEGFR-2 and Tie2 receptor expression in breast carcinoma Int J Oncol 26 977 84 15753992 1:CAS:528:DC%2BD2MXjtFelsb8%3D
26. E Mylona P Alexandrou I Giannopoulou, et al. 2007 The prognostic value of vascular endothelial growth factors (VEGFs)-A and -B and their receptor, VEGFR-1, in invasive breast carcinoma Gynecol Oncol 104 557 63 17150246 1:CAS:528:DC%2BD2sXitFOgsL0%3D 10.1016/j.ygyno.2006.09.031
27. C Trastour E Benizri F Ettore, et al. 2007 HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome Int J Cancer 120 1451 8 17245699 1:CAS:528:DC%2BD2sXis12is7Y%3D 10.1002/ijc.22436 (Pubitemid 46355379)
28. DF Hayes K Miller G Sledge 2007 Angiogenesis as targeted breast cancer therapy Breast 16 Suppl 2 S17 19 17707641 10.1016/j.breast.2007.07.003 (Pubitemid 350028550)
29. T Namba H Koike K Murakami, et al. 2003 Angiogenesis induced by endothelial nitric oxide synthase gene through vascular endothelial growth factor expression in a rat hindlimb ischemia model Circulation 108 2250 7 14568906 1:CAS:528:DC%2BD3sXosVShs7k%3D 10.1161/01.CIR.0000093190.53478.78 (Pubitemid 37363043)
30. A Duenas-Gonzalez CM Isales Abad-Hernandez M del Mar R Gonzalez-Sarmiento O Sangueza J Rodriguez-Commes 1997 Expression of inducible nitric oxide synthase in breast cancer correlates with metastatic disease Mod Pathol 10 645 9 9237172 1:STN:280:DyaK2szotVersQ%3D%3D (Pubitemid 27321753)
31. MM Vleugel AE Greijer A Shvarts, et al. 2005 Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer J Clin Pathol 58 172 7 15677538 1:CAS:528:DC%2BD2MXhvFCqu7g%3D 10.1136/jcp.2004.019885 (Pubitemid 40193803)
32. K Lundgren C Holm G Landberg 2007 Hypoxia and breast cancer: prognostic and therapeutic implications Cell Mol Life Sci 64 3233 47 17957335 1:CAS:528:DC%2BD1cXmtVylug%3D%3D 10.1007/s00018-007-7390-6
33. M Lechner P Lirk J Rieder 2005 Inducible nitric oxide synthase (iNOS) in tumor biology: the two sides of the same coin Semin Cancer Biol 15 277 89 15914026 1:CAS:528:DC%2BD2MXmvVKntb4%3D 10.1016/j.semcancer.2005.04.004 (Pubitemid 41058773)
34. S Loibl A Buck C Strank, et al. 2005 The role of early expression of inducible nitric oxide synthase in human breast cancer Eur J Cancer 41 265 71 15661552 1:CAS:528:DC%2BD2MXmvFWisA%3D%3D 10.1016/j.ejca.2004.07.010 (Pubitemid 40126959)
35. M Vakkala P Paakko Y Soini 2000 eNOS expression is associated with the estrogen and progesterone receptor status in invasive breast carcinoma Int J Oncol 17 667 71 10995876 1:CAS:528:DC%2BD3cXntFOmurs%3D
36. D Sumi LJ Ignarro 2003 Estrogen-related receptor alpha 1 up-regulates endothelial nitric oxide synthase expression Proc Natl Acad Sci USA 100 14451 6 14610283 1:CAS:528:DC%2BD3sXpsFGhsL8%3D 10.1073/pnas.2235590100 (Pubitemid 37499257)
37. S Loibl J Bratengeier V Farines, et al. 2006 Investigations on the inducible and endothelial nitric oxide synthases in human breast cancer cell line MCF-7 - estrogen has an influence on e-NOS, but not on i-NOS Pathol Res Pract 202 1 7 16326029 1:CAS:528:DC%2BD28XhsFyntL4%3D 10.1016/j.prp.2005.10.003 (Pubitemid 43115585)
38. KM Gavin DR Seals AE Silver KL Moreau 2009 Vascular endothelial estrogen receptor alpha is modulated by estrogen status and related to endothelial function and endothelial nitric oxide synthase in healthy women J Clin Endocrinol Metab 94 3513 20 19509105 1:CAS:528:DC%2BD1MXhtFChtL%2FF 10.1210/jc.2009-0278
39. A Oishi M Ohmichi K Takahashi, et al. 2004 Medroxyprogesterone acetate attenuates estrogen-induced nitric oxide production in human umbilical vein endothelial cells Biochem Biophys Res Commun 324 193 8 15465001 1:CAS:528:DC%2BD2cXot1WksbY%3D 10.1016/j.bbrc.2004.09.032 (Pubitemid 39311477)
40. M Zerr-Fouineau M Chataigneau C Blot VB Schini-Kerth 2007 Progestins overcome inhibition of platelet aggregation by endothelial cells by down-regulating endothelial NO synthase via glucocorticoid receptors FASEB J 21 265 73 17116740 1:CAS:528:DC%2BD2sXmvFChsw%3D%3D 10.1096/fj.06-6840com (Pubitemid 46052565)
41. JT Chi Z Wang DS Nuyten, et al. 2006 Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers PLoS Med 3 e47 16417408 10.1371/journal.pmed.0030047
42. M Milani AL Harris 2008 Targeting tumour hypoxia in breast cancer Eur J Cancer 44 2766 73 18990559 1:CAS:528:DC%2BD1cXhsVKltr%2FI 10.1016/j.ejca.2008. 09.025
43. J Kurebayashi T Otsuki T Moriya H Sonoo 2001 Hypoxia reduces hormone responsiveness of human breast cancer cells Jpn J Cancer Res 92 1093 101 11676860 1:CAS:528:DC%2BD3MXptVGgu74%3D 10.1111/j.1349-7006.2001.tb01064.x (Pubitemid 33041178)
44. Y Yamamoto M Ibusuki Y Okumura, et al. 2008 Hypoxia-inducible factor 1alpha is closely linked to an aggressive phenotype in breast cancer Breast Cancer Res Treat 110 465 75 17805961 1:CAS:528:DC%2BD1cXosVOgt7s%3D 10.1007/s10549-007-9742-1 (Pubitemid 351962589)
45. E Laughner P Taghavi K Chiles PC Mahon GL Semenza 2001 HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression Mol Cell Biol 21 3995 4004 11359907 1:CAS:528:DC%2BD3MXktFWgtL4%3D 10.1128/MCB.21.12.3995-4004.2001 (Pubitemid 32476461)
46. A Giatromanolaki MI Koukourakis C Simopoulos, et al. 2004 c-erbB-2 related aggressiveness in breast cancer is hypoxia inducible factor-1alpha dependent Clin Cancer Res 10 7972 7 15585632 1:CAS:528:DC%2BD2cXhtVCrs7rO 10.1158/1078-0432.CCR-04-1068 (Pubitemid 39587538)
47. TA Traina HS Rugo M Dickler 2007 Bevacizumab for advanced breast cancer Hematol Oncol Clin North Am 21 303 19 17512451 10.1016/j.hoc.2007.03.006 (Pubitemid 46754733)
48. M Marty X Pivot 2008 The potential of anti-vascular endothelial growth factor therapy in metastatic breast cancer: Clinical experience with anti-angiogenic agents, focusing on bevacizumab Eur J Cancer 44 912 20 18396037 1:CAS:528:DC%2BD1cXlslWltrw%3D 10.1016/j.ejca.2008.01.005
49. S Patiar AL Harris 2006 Role of hypoxia-inducible factor-1alpha as a cancer therapy target Endocr Relat Cancer 13 Suppl 1 S61 75 17259560 1:CAS:528:DC%2BD2sXivF2mtbw%3D 10.1677/erc.1.01290 (Pubitemid 46219249)
50. G Melillo 2007 Targeting hypoxia cell signaling for cancer therapy Cancer Metastasis Rev 26 341 52 17415529 1:CAS:528:DC%2BD2sXotFWrtb4%3D 10.1007/s10555-007-9059-x (Pubitemid 47101663)
51. F Coulet S Nadaud M Agrapart F Soubrier 2003 Identification of hypoxia-response element in the human endothelial nitric-oxide synthase gene promoter J Biol Chem 278 46230 40 12963737 1:CAS:528:DC%2BD3sXovFKlt7k%3D 10.1074/jbc.M305420200 (Pubitemid 37452193)